Reinsurance Group of America EVP exercises 1,401 rights

Q: How many RGA shares did Arthur Ozeki receive from exercising his stock appreciation rights?

Arthur Ozeki exercised 1,401 stock appreciation rights on November 10, 2026, at $129.72 per share, acquiring 1,401 common shares. Of those, 664 shares were withheld for the exercise price, resulting in a net settlement of 737 common shares; no shares were withheld for taxes.

Q: When were Arthur Ozeki’s RGA stock appreciation rights granted, and what was their vesting schedule?

The rights were granted on March 3, 2017, and vested in 25% increments over four years, starting on December 31 of the year of grant.

Available on EDGAR 11/13/2026 - 04:08 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:07 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Reinsurance Group of America (RGA) executive Arthur Ozeki, EVP, Head of Asia Pacific, exercised 1,401 stock appreciation rights on November 10, 2026, at an exercise price of $129.72 per share. The exercise produced 1,401 common shares; 664 shares were withheld to cover the exercise price, resulting in a net settlement of 737 common shares. No shares were withheld for taxes.

Insider Trade Summary

1,401 shares exercised/converted

Exercise 3 txns

Insider Ozeki Arthur

Role EVP, Head of Asia Pacific

Type	Security	Shares	Price	Value
Exercise	Stock Appreciation Right (right to purchase) 2017 ^F2	1,401	$0.00	$0.00
Exercise	Common stock	1,401	$129.72	$182K
Exercise Price or Tax Liability	Common stock ^F1	664	$274.06	$182K

Holdings After Transaction: Stock Appreciation Right (right to purchase) 2017 — 0 rights (Direct); Common stock — 13,773 shares (Direct)

Holdings Before and After: Stock Appreciation Right (right to purchase) 2017, 1,401 to 0 rights (Direct); Common stock, 13,036 to 13,773 shares (Direct)

Footnotes (2)

F1. Represents 664 shares withheld to cover the exercise price of the stock appreciation rights, resulting in a net settlement of 737 shares of Common Stock. No shares were withheld for taxes.
F2. Stock appreciation rights settle in Common Stock, vest in 25% increments over four years, starting on December 31 of the year of grant. The stock appreciation rights were granted on March 3, 2017.

Key Figures

Stock appreciation rights exercised: 1,401 rights Exercise price: $129.72 per share Common shares acquired: 1,401 shares +3 more

6 metrics

Stock appreciation rights exercised 1,401 rights November 10, 2026

Exercise price $129.72 per share Stock appreciation rights exercised November 10, 2026

Common shares acquired 1,401 shares Upon exercise on November 10, 2026

Shares withheld for exercise price 664 shares No shares were withheld for taxes

Net settlement 737 common shares Result of the stock appreciation rights exercise

Stock appreciation rights after transaction 0 rights Reported position following the exercise

Key Terms

Stock Appreciation Right, net settlement

2 terms

Stock Appreciation Right financial

"Stock Appreciation Right (right to purchase) 2017"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

net settlement financial

"resulting in a net settlement of 737 shares of Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RGA shares did Arthur Ozeki receive from exercising his stock appreciation rights?

Arthur Ozeki exercised 1,401 stock appreciation rights on November 10, 2026, at $129.72 per share, acquiring 1,401 common shares. Of those, 664 shares were withheld for the exercise price, resulting in a net settlement of 737 common shares; no shares were withheld for taxes.

When were Arthur Ozeki’s RGA stock appreciation rights granted, and what was their vesting schedule?

The rights were granted on March 3, 2017, and vested in 25% increments over four years, starting on December 31 of the year of grant.

When were Arthur Ozeki’s RGA stock appreciation rights due to expire?

The reported stock appreciation rights had an expiration date of March 3, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ozeki Arthur

(Last)

(First)

(Middle)

16600 SWINGLEY RIDGE RD.

(Street)

CHESTERFIELD

MISSOURI

63017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
REINSURANCE GROUP OF AMERICA INC [ RGA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Head of Asia Pacific

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	11/10/2026		M		1,401	A	$129.72	14,437	D
Common stock	11/10/2026		F		664⁽¹⁾	D	$274.06	13,773	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Appreciation Right (right to purchase) 2017	$129.72	11/10/2026		M			1,401	⁽²⁾	03/03/2027	Common stock	1,401	$0	0	D

Explanation of Responses:

1. Represents 664 shares withheld to cover the exercise price of the stock appreciation rights, resulting in a net settlement of 737 shares of Common Stock. No shares were withheld for taxes.

2. Stock appreciation rights settle in Common Stock, vest in 25% increments over four years, starting on December 31 of the year of grant. The stock appreciation rights were granted on March 3, 2017.

Remarks:

	/s/ My Chi To, by Power of Attorney	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR